ZIOPHARM ONCOLOGY INC (ZIOP) Stock News

NASDAQ:ZIOP - Nasdaq - Common Stock

0.8657 -0.01 (-0.88%)

After market: 0.88 +0.01 (+1.65%)

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

ZIOP Latest News, Press Relases and Analysis

All

Press Releases

3 years ago - By: CARsgen Therapeutics - Mentions: TCRT

CARsgen Appoints Dr. Raffaele Baffa as Chief Medical Officer

4 years ago - By: Benzinga

Ziopharm Rebrands As Alaunos Therapeutics

4 years ago - By: Benzinga - Mentions: GILD IBB MNOV VRTX ...

The Daily Biotech Pulse: Gilead's Blood Cancer Studies Placed On Partial Clinical Hold, Immunocore Gets FDA Nod, NRx Touts Positive COVID-19 Data

4 years ago - By: ZIOPHARM Oncology Inc

Ziopharm Oncology Highlights Operational Progress & Rebrands to Alaunos Therapeutics

4 years ago - By: Zacks Investment Research

ZIOPHARM Oncology (ZIOP) Sees Hammer Chart Pattern: Time to Buy?

4 years ago - By: ZIOPHARM Oncology Inc

Ziopharm Oncology Presents Preclinical Data Supporting TCR-T Library Approach at the Society for Immunotherapy of Cancer 2021 Annual Meeting

4 years ago - By: ZIOPHARM Oncology Inc

Ziopharm Oncology Reports Third Quarter 2021 Financial Results and Provides Business Update

4 years ago - By: ZIOPHARM Oncology Inc

Ziopharm Oncology to Report Third Quarter Financial Results on November 8, 2021

4 years ago - By: PennyStocks.com - Mentions: GME AMC CEI FTFT ...

Best Penny Stocks To Buy Right Now? 3 Short Squeeze Stocks To Watch

4 years ago - By: Zacks Investment Research - Mentions: REGN IRWD MRNA

Ziopharm (ZIOP) Down on Workforce Reduction Announcement

4 years ago - By: The Business Journals

Ziopharm Oncology cuts more than half its staff

4 years ago - By: The Motley Fool

Here's Why Ziopharm Oncology Stock Is Up 18% This Week

4 years ago - By: Zacks Investment Research

Is the Options Market Predicting a Spike ZIOPHARM (ZIOP) Stock?